As of Dec 8, 2018 Aceto Corporation (NASDAQ:ACET) Shorts Reduced By 14.36%

During 2018 Q2 the big money sentiment decreased to 0.7. That’s change of 0.79, from 2018Q1’s 1.49. 30 investors sold all, 34 reduced holdings as Aceto Corporation ratio turned negative. 23 grew stakes while 22 funds bought stakes. Funds hold 17.09 million shares thus 20.15% less from 2018Q1’s 21.41 million shares.
Mutual Of America Limited Liability Corporation owns 113 shs for 0% of their capital. Comerica Fincl Bank holds 0% or 31,208 shs in its capital. Tower Rech Capital (Trc) owns 7,485 shs or 0% of their US capital. Moreover, Millennium Mgmt Limited Liability Company has 0% invested in Aceto Corporation (NASDAQ:ACET) for 258,251 shs. Guggenheim Limited Liability Co reported 27,884 shs. Element Mgmt Ltd Com owns 120,535 shs or 0.01% of their US capital. Mason Street Ltd Liability Com has invested 0% of its capital in Aceto Corporation (NASDAQ:ACET). Hartford reported 51,079 shs. Barclays Public Ltd owns 64,936 shs or 0% of their US capital. 222,131 were reported by Ameriprise Fincl. Moreover, Price T Rowe Associate Md has 0% invested in Aceto Corporation (NASDAQ:ACET) for 29,500 shs. Jpmorgan Chase & Co invested 0% in Aceto Corporation (NASDAQ:ACET). Legal General Grp Plc reported 0% in Aceto Corporation (NASDAQ:ACET). Geode Capital Management Lc reported 0% in Aceto Corporation (NASDAQ:ACET). Pnc Fincl Group Inc holds 0% or 15,938 shs in its capital.

Aceto Corporation registered $131,986 net activity with 0 insider buys and 15 sales since July 3, 2018. On Friday, October 5 $2,041 worth of Aceto Corporation (NASDAQ:ACET) was sold by DEBENEDITTIS FRANK. Shares for $2,017 were sold by Scally Frances P. Kaczmarek Walter J III also sold $21,302 worth of Aceto Corporation (NASDAQ:ACET) on Friday, September 7. $35,220 worth of Aceto Corporation (NASDAQ:ACET) was sold by EILENDER ALBERT L. 1,230 shs were sold by Rogers Steven, worth $4,539 on Thursday, July 5.

It was registered a decrease on Aceto Corporation (NASDAQ:ACET)’s short interest with 14.36%. In December was issued ACET’s total 933,700 short interest by FINRA. Previously was reported down change of 14.36% from 1.09M shares. With Average volume 186,300, ACET’s former position will take 5 days to recover. Aceto Corporation’s short interest float is 3.17%.

ACET is reaching $1.46 during the last trading session, after decreased 2.67%.Currently Aceto Corporation is downtrending after 71.48% change in last December 8, 2017. ACET has also 155,161 shares volume. The stock underperformed the S&P 500 by 87.10%.

Aceto Corporation, together with its subsidiaries, sources, markets, sells, and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products, and specialty chemicals.The company has $44.97 million market cap. The firm operates in three divisions: Human Health, Pharmaceutical Ingredients, and Performance Chemicals.Last it reported negative earnings. The Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements, including vitamins, amino acids, iron compounds, and bio chemicals used in pharmaceutical and nutritional preparations.

For more Aceto Corporation (NASDAQ:ACET) news released recently go to:,,, or The titles are as follows: “ACETO Reports Fiscal 2018 Second Quarter Results Nasdaq:ACET – GlobeNewswire” released on February 01, 2018, “ACETO Reports Fiscal 2019 First Quarter Results Nasdaq:ACET – GlobeNewswire” on November 08, 2018, “ACETO Reports Fiscal 2018 Third Quarter Results Nasdaq:ACET – GlobeNewswire” with a publish date: May 03, 2018, “ACETO Appoints Edward J. Borkowski Chief Financial Officer – GlobeNewswire” and the last “Lawsuit for Investors in NASDAQ: ACET shares against Aceto Corporation announced by Shareholders Foundation – GlobeNewswire” with publication date: September 17, 2018.

Aceto Corporation (NASDAQ:ACET) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.